{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:49:16Z","timestamp":1793364556073,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Aceclofenac (ACF), a Non-Steroidal Anti-Inflammatory Drug (NSAID), is formulated with Soluplus\u00ae (SOLP) to enhance solubility and bioavailability. This study presents a distinct approach by utilizing Hot Melt Extrusion (HME) to prepare Aceclofenac-Soluplus\u00ae solid dispersion (ACF-SOLP), in contrast to the previously investigated nanoemulsion technique. The HME technique facilitates a uniform drug distribution within the polymer matrix, increasing ACF's dissolution rate. Different weight ratios of ACF and SOLP were assessed with 1:8 (HM4), which proved to be the optimal choice. ACF is dispersed within SOLP in its amorphous state, and HM4 exhibited a significant increase in drug release as compared to pure ACF and its physical mixture. I<jats:italic>n vivo<\/jats:italic> pharmacokinetic data of HM4 demonstrated a drastic improvement in the C<jats:sub>max<\/jats:sub> (7.1\u2009\u00b1\u20090.14\u00a0\u00b5g\/ml) and AUC (12.1\u2009\u00b1\u20091.30\u00a0\u00b5g-h\/ml). Further, molecular dynamics simulation revealed that the polymer is widely dispersed within the supramolecular architecture of ACF-SOLP, with ACF positioned centrally, confirming the favorable interactions between the components. Leveraging the hydrophilic nature of the SOLP, the solid dispersion demonstrated enhanced dissolution of ACF, while HME synergistically reinforced the combination. This approach presents a compelling alternative to traditional methods, unlocking new possibilities for formulating poorly soluble drugs.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1208\/s12249-025-03173-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:24:59Z","timestamp":1751387099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hot Melt Extruded Aceclofenac-Soluplus\u00ae Solid Dispersion: Mechanistic View of Miscibility and Drug-Carrier Interactions for Enhanced Dissolution"],"prefix":"10.1208","volume":"26","author":[{"given":"Likhitha","family":"U","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roushan","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reema","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-3114","authenticated-orcid":false,"given":"Usha Yogendra","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"3173_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1208\/s12249-015-0393-y","volume":"17","author":"JS LaFountaine","year":"2016","unstructured":"LaFountaine JS, McGinity JW, Williams RO. Challenges and strategies in thermal processing of amorphous solid dispersions: a review. AAPS PharmSciTech. 2016;17(1):43\u201355. https:\/\/doi.org\/10.1208\/s12249-015-0393-y.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3173_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.AJPS.2014.08.005","volume":"10","author":"VB Junyaprasert","year":"2015","unstructured":"Junyaprasert VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10(1):13\u201323. https:\/\/doi.org\/10.1016\/J.AJPS.2014.08.005.","journal-title":"Asian J Pharm Sci"},{"key":"3173_CR3","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.2147\/IJN.S141504","volume":"12","author":"R Narayan","year":"2017","unstructured":"Narayan R, Pednekar A, Bhuyan D, Gowda CKK, Nayak UY. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies. Int J Nanomedicine. 2017;12:4921\u201335. https:\/\/doi.org\/10.2147\/IJN.S141504.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3173_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.IJPHARM.2012.10.043","volume":"453","author":"R Thakuria","year":"2013","unstructured":"Thakuria R, Delori A, Jones W, Lipert MP, Roy L, Rodr\u00edguez-Hornedo N. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 2013;453(1):101\u201325. https:\/\/doi.org\/10.1016\/J.IJPHARM.2012.10.043.","journal-title":"Int J Pharm"},{"issue":"1","key":"3173_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5958\/0974-360X.2017.00007.5","volume":"10","author":"JE Thomas","year":"2017","unstructured":"Thomas JE, Nayak UY, Jagadish P, Koteshwara K. Design and characterization of valsartan co-crystals to improve its aqueous solubility and dissolution behavior. Res J Pharm Technol. 2017;10(1):26\u201330. https:\/\/doi.org\/10.5958\/0974-360X.2017.00007.5.","journal-title":"Res J Pharm Technol"},{"key":"3173_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.MOLLIQ.2018.02.131","volume":"259","author":"V Suvarna","year":"2018","unstructured":"Suvarna V, Thorat S, Nayak U, Sherje A, Murahari M. Host-guest interaction study of Efavirenz with hydroxypropyl-\u03b2-cyclodextrin and l-arginine by computational simulation studies: Preparation and characterization of supramolecular complexes. J Mol Liq. 2018;259:55\u201364. https:\/\/doi.org\/10.1016\/J.MOLLIQ.2018.02.131.","journal-title":"J Mol Liq"},{"issue":"1\u20132","key":"3173_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10847-018-0797-x","volume":"91","author":"A Chandra","year":"2018","unstructured":"Chandra A, Ghate MV, Aithal KS, Lewis SA. In silico prediction coupled with in vitro experiments and absorption modeling to study the inclusion complex of telmisartan with modified beta-cyclodextrin. J Incl Phenom Macrocycl Chem. 2018;91(1\u20132):47\u201360. https:\/\/doi.org\/10.1007\/s10847-018-0797-x.","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"6","key":"3173_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1080\/03639045.2018.1428339","volume":"44","author":"S Deshmane","year":"2018","unstructured":"Deshmane S, Deshmane S, Shelke S, Biyani K. Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study. Drug Dev Ind Pharm. 2018;44(6):1001\u201311. https:\/\/doi.org\/10.1080\/03639045.2018.1428339.","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"3173_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15171\/apb.2017.068","volume":"7","author":"M Chaturvedi","year":"2017","unstructured":"Chaturvedi M, Kumar M, Pathak K, Bhatt S, Saini V. Surface solid dispersion and solid dispersion of meloxicam: Comparison and product development. Adv Pharm Bull. 2017;7(4):569\u201377. https:\/\/doi.org\/10.15171\/apb.2017.068.","journal-title":"Adv Pharm Bull"},{"key":"3173_CR10","doi-asserted-by":"publisher","unstructured":"Karasulu HY, Gundogdu E, Turk UO, Turgay T, Apayd\u0131n S, Simsir IY, et al. Enhancing Solubility and Bioavailability of Rosuvastatin into Self Emulsifying Drug Delivery System. Curr Drug Deliv 2018;15. https:\/\/doi.org\/10.2174\/1567201815666180226114545","DOI":"10.2174\/1567201815666180226114545"},{"key":"3173_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.colsurfb.2014.11.022","volume":"126","author":"AG Agrawal","year":"2015","unstructured":"Agrawal AG, Kumar A, Gide PS. Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide. Colloids Surf B Biointerfaces. 2015;126:553\u201360. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.11.022.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"3173_CR12","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/J.DDTEC.2011.10.002","volume":"9","author":"G Van den Mooter","year":"2012","unstructured":"Van den Mooter G. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discov Today Technol. 2012;9(2):e79-85. https:\/\/doi.org\/10.1016\/J.DDTEC.2011.10.002.","journal-title":"Drug Discov Today Technol"},{"issue":"10","key":"3173_CR13","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/jps.24541","volume":"104","author":"Y He","year":"2015","unstructured":"He Y, Ho C. Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci. 2015;104(10):3237\u201358. https:\/\/doi.org\/10.1002\/jps.24541.","journal-title":"J Pharm Sci"},{"issue":"9","key":"3173_CR14","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527\u201344. https:\/\/doi.org\/10.1016\/j.xphs.2015.10.008.","journal-title":"J Pharm Sci"},{"key":"3173_CR15","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/195727","volume":"2012","author":"KT Savjani","year":"2012","unstructured":"Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012: 195727. https:\/\/doi.org\/10.5402\/2012\/195727.","journal-title":"ISRN Pharm"},{"issue":"1","key":"3173_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12249-015-0360-7","volume":"17","author":"H Patil","year":"2016","unstructured":"Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20\u201342. https:\/\/doi.org\/10.1208\/s12249-015-0360-7.","journal-title":"AAPS PharmSciTech"},{"key":"3173_CR17","first-page":"105","volume":"35","author":"\u015e Akku\u015fArslan","year":"2010","unstructured":"Akku\u015fArslan \u015e, Tirnaksiz F. A nonsteroidal antiinflammatory drug: Aceclofenac. FABAD J Pharm Sci. 2010;35:105\u201318.","journal-title":"FABAD J Pharm Sci"},{"issue":"4","key":"3173_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1166\/jbt.2017.1571","volume":"7","author":"LB Shi","year":"2017","unstructured":"Shi LB, Tang PF, Zhang W, Zhao YP, Zhang LC, Zhang H. Aceclofenac-HYDROXYPROPYL- \u03b2 -cyclodextrin complex for prolonged and improved drug delivery for orthopedic applications. J Biomater Tissue Eng. 2017;7(4):327\u201332. https:\/\/doi.org\/10.1166\/jbt.2017.1571.","journal-title":"J Biomater Tissue Eng"},{"issue":"3","key":"3173_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4103\/0975-7406.84457","volume":"3","author":"K Dua","year":"2011","unstructured":"Dua K, Pabreja K, Ramana MV, Lather V. Dissolution behavior of \u03b2-cyclodextrin molecular inclusion complexes of aceclofenac. J Pharm Bioallied Sci. 2011;3(3):417\u201325. https:\/\/doi.org\/10.4103\/0975-7406.84457.","journal-title":"J Pharm Bioallied Sci"},{"issue":"1","key":"3173_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4172\/jbb.1000007","volume":"1","author":"F Shakeel","year":"2009","unstructured":"Shakeel F, Ramadan W, Shafiq S. Solubility and dissolution improvement of aceclofenac using different nanocarriers. J Bioequivalence Bioavailab. 2009;1(1):39\u201343. https:\/\/doi.org\/10.4172\/jbb.1000007.","journal-title":"J Bioequivalence Bioavailab"},{"issue":"1\u20132","key":"3173_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ijpharm.2007.09.006","volume":"350","author":"S Mutalik","year":"2008","unstructured":"Mutalik S, Anju P, Manoj K, Usha AN. Enhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approach. Int J Pharm. 2008;350(1\u20132):279\u201390. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.09.006.","journal-title":"Int J Pharm"},{"issue":"6","key":"3173_CR22","first-page":"1288","volume":"3","author":"R Sodanapalli","year":"2011","unstructured":"Sodanapalli R, Nair R. Synthesis and Characterization of a Pharmaceutical Co-Crystal: (Aceclofenac: Nicotinamide). J Pharm Sci Res. 2011;3(6):1288\u201393.","journal-title":"J Pharm Sci Res"},{"issue":"1","key":"3173_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1567201817666200817110949","volume":"18","author":"S Kumar","year":"2020","unstructured":"Kumar S, Gupta A, Prasad R, Singh S. Novel aceclofenac cocrystals with l-cystine: virtual coformer screening, mechanochemical synthesis, and physicochemical investigations. Curr Drug Deliv. 2020;18(1):88\u2013100. https:\/\/doi.org\/10.2174\/1567201817666200817110949.","journal-title":"Curr Drug Deliv"},{"key":"3173_CR24","doi-asserted-by":"publisher","unstructured":"Afzal H, Abbas N, Hussain A, Latif S, Fatima K, Arshad MS, et al. Physicomechanical, stability, and pharmacokinetic evaluation of aceclofenac dimethyl urea cocrystals. AAPS PharmSciTech 2021;22(2). https:\/\/doi.org\/10.1208\/s12249-021-01938-7","DOI":"10.1208\/s12249-021-01938-7"},{"issue":"1\u20133","key":"3173_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/J.POWTEC.2010.10.009","volume":"207","author":"FA Maulvi","year":"2011","unstructured":"Maulvi FA, Dalwadi SJ, Thakkar VT, Soni TG, Gohel MC, Gandhi TR. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol. 2011;207(1\u20133):47\u201354. https:\/\/doi.org\/10.1016\/J.POWTEC.2010.10.009.","journal-title":"Powder Technol"},{"issue":"2","key":"3173_CR26","first-page":"146","volume":"2","author":"BAMR Shivalingam","year":"2010","unstructured":"Shivalingam BAMR, Reddy YVK, Rao S, Sunitha KRN. Formulation and evaluation of aceclofenac solid dispersions for dissolution rate enhancement. Int J Pharmaceut Sci Drug Res. 2010;2(2):146\u201350.","journal-title":"Int J Pharmaceut Sci Drug Res"},{"issue":"7","key":"3173_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/0113892002330772240912055518","volume":"25","author":"MA Mujtaba","year":"2024","unstructured":"Mujtaba MA, Fule R, Amin P, Elhassan GO, Almoutairi MMM, Kaleem M, et al. Development of hot melt extruded co-formulated artesunate and amodiaquine- soluplus\u00ae solid dispersion system in fixed-dose form: amorphous state characterization and pharmacokinetic evaluation. Curr Drug Metab. 2024;25(7):505\u201322. https:\/\/doi.org\/10.2174\/0113892002330772240912055518.","journal-title":"Curr Drug Metab"},{"key":"3173_CR28","doi-asserted-by":"publisher","unstructured":"Saraf I, Jakasanovski O, Stani\u0107 T, Kralj E, Petek B, Williams JD, et al. Investigation of the Influence of Copovidone Properties and Hot-Melt Extrusion Process on Level of Impurities, In Vitro Release, and Stability of an Amorphous Solid Dispersion Product. Mol Pharm Published online November 4, 2024. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00707","DOI":"10.1021\/acs.molpharmaceut.4c00707"},{"issue":"12","key":"3173_CR29","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/03639045.2020.1821045","volume":"46","author":"H Wu","year":"2020","unstructured":"Wu H, Liu Y, Ci T, Ke X. Application of HPMC HME polymer as hot melt extrusion carrier in carbamazepine solid dispersion. Drug Dev Ind Pharm. 2020;46(12):1911\u20138. https:\/\/doi.org\/10.1080\/03639045.2020.1821045.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"3173_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/ajprhc.ajprhc_50_23","volume":"16","author":"M Nijhawan","year":"2024","unstructured":"Nijhawan M, Sirisha N, Bhavana J, Neelima R, Aleti R, Sailaja G, et al. Formulation and evaluation of solid dispersion of felodipine by hot melt extrusion for enhancement of solubility. Asian J Pharmaceut Res Health Care. 2024;16(2):178\u201383. https:\/\/doi.org\/10.4103\/ajprhc.ajprhc_50_23.","journal-title":"Asian J Pharmaceut Res Health Care"},{"key":"3173_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejpb.2023.05.008","volume":"188","author":"SM Tambe","year":"2023","unstructured":"Tambe SM, Jain DD, Hasmukh Mehta C, Ashwini T, YogendraNayak U, Amin PD. Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies. Eur J Pharm Biopharm. 2023;188:108\u201324. https:\/\/doi.org\/10.1016\/j.ejpb.2023.05.008.","journal-title":"Eur J Pharm Biopharm"},{"key":"3173_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-024-00724-4","author":"DH Ha","year":"2025","unstructured":"Ha DH, Ha ES, Park H, Lee SK, Jeong JS, Kang HT, et al. Enhanced oral bioavailability of pranlukast by preparing amorphous solid dispersion via hot-melt extrusion. J Pharm Investig Published online. 2025. https:\/\/doi.org\/10.1007\/s40005-024-00724-4.","journal-title":"J Pharm Investig Published online"},{"issue":"6","key":"3173_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/10837450.2016.1256409","volume":"23","author":"NQ Shi","year":"2018","unstructured":"Shi NQ, Lai HW, Zhang Y, Feng B, Xiao X, Zhang HM, et al. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology. Pharm Dev Technol. 2018;23(6):573\u201386. https:\/\/doi.org\/10.1080\/10837450.2016.1256409.","journal-title":"Pharm Dev Technol"},{"key":"3173_CR34","doi-asserted-by":"publisher","first-page":"789765","DOI":"10.1155\/2014\/789765","volume":"2014","author":"U Paaver","year":"2014","unstructured":"Paaver U, Tamm I, Laidm\u00e4e I, Lust A, Kirsim\u00e4e K, Veski P, et al. Soluplus graft copolymer: potential novel carrier polymer in electrospinning of nanofibrous drug delivery systems for wound therapy. Biomed Res Int. 2014;2014:789765. https:\/\/doi.org\/10.1155\/2014\/789765.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3173_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejpb.2012.12.018","volume":"84","author":"J Djuris","year":"2013","unstructured":"Djuris J, Nikolakakis I, Ibric S, Djuric Z, Kachrimanis K. Preparation of carbamazepine\u2013Soluplus\u00ae solid dispersions by hot-melt extrusion, and prediction of drug\u2013polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm. 2013;84(1):228\u201337. https:\/\/doi.org\/10.1016\/j.ejpb.2012.12.018.","journal-title":"Eur J Pharm Biopharm"},{"key":"3173_CR36","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2147\/DDDT.S84070","volume":"9","author":"HJ Cho","year":"2015","unstructured":"Cho HJ, Lee JY, Kang WS, Piao J, Yoon IS, Kim DD. Soluplus&reg;\/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Drug Des Devel Ther. 2015;9:2745\u201356. https:\/\/doi.org\/10.2147\/DDDT.S84070.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3173_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1208\/s12249-024-03007-1","volume":"26","author":"MY Zhao","year":"2025","unstructured":"Zhao MY, Shi XB, Chang JH, Wang RX, Zhou JY, Liu P. Amorphous solid dispersions of glycyrrhetinic acid: using soluplus, PVP, and PVPVA as the polymer matrix to enhance solubility, bioavailability, and stability. AAPS PharmSciTech. 2025;26(1):18. https:\/\/doi.org\/10.1208\/s12249-024-03007-1.","journal-title":"AAPS PharmSciTech"},{"issue":"02","key":"3173_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4236\/snl.2015.52003","volume":"05","author":"S Patnaik","year":"2015","unstructured":"Patnaik S, Aditha SK, Rattan T, Kamisetti V. Aceclofenac-Soluplus&reg Nanocomposites for Increased Bioavailability. Soft Nanoscience Letters. 2015;05(02):13\u201320. https:\/\/doi.org\/10.4236\/snl.2015.52003.","journal-title":"Soft Nanoscience Letters"},{"issue":"2","key":"3173_CR39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/J.EJPB.2008.06.010","volume":"70","author":"AN Usha","year":"2008","unstructured":"Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N. Preparation and in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Eur J Pharm Biopharm. 2008;70(2):674\u201383. https:\/\/doi.org\/10.1016\/J.EJPB.2008.06.010.","journal-title":"Eur J Pharm Biopharm"},{"key":"3173_CR40","doi-asserted-by":"publisher","first-page":"128052","DOI":"10.1016\/j.molstruc.2020.128052","volume":"1211","author":"U Likhitha","year":"2020","unstructured":"Likhitha U, Narayana B, Sarojini BK, Madan Kumar S, Lobo AG, Karthick T. A study on interwoven hydrogen bonding interactions in new zidovudine-picric acid (1:1) cocrystal through single crystal XRD, spectral and computational methods. J Mol Struct. 2020;1211:128052. https:\/\/doi.org\/10.1016\/j.molstruc.2020.128052.","journal-title":"J Mol Struct"},{"key":"3173_CR41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.molstruc.2019.06.037","volume":"1195","author":"U Likhitha","year":"2019","unstructured":"Likhitha U, Narayana B, Sarojini BK, Lobo AG, Sharma G, Pathania S, et al. Do hydrogen bonding and noncovalent interactions stabilize nicotinamide-picric acid cocrystal supramolecular assembly? J Mol Struct. 2019;1195:827\u201338. https:\/\/doi.org\/10.1016\/j.molstruc.2019.06.037.","journal-title":"J Mol Struct"},{"key":"3173_CR42","doi-asserted-by":"publisher","first-page":"134373","DOI":"10.1016\/j.molstruc.2022.134373","volume":"1273","author":"MRP Rao","year":"2023","unstructured":"Rao MRP, Sonawane AS, Sapate SA, Mehta CH, Nayak UY. Molecular modeling and in vitro studies to assess solubility enhancement of nevirapine by solid dispersion technique. J Mol Struct. 2023;1273:134373. https:\/\/doi.org\/10.1016\/j.molstruc.2022.134373.","journal-title":"J Mol Struct"},{"key":"3173_CR43","doi-asserted-by":"publisher","first-page":"129284","DOI":"10.1016\/j.molstruc.2020.129284","volume":"1225","author":"U Likhitha","year":"2021","unstructured":"Likhitha U, Narayana B, Sarojini BK, Madan Kumar S, Karthick T. Crystallographic and theoretical interpretation of supramolecular architecture in a new salt hydrate of DL-Tartaric acid and Dimethylamine (DLTA-DA). J Mol Struct. 2021;1225:129284. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129284.","journal-title":"J Mol Struct"},{"key":"3173_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.msec.2017.02.063","volume":"75","author":"GV Shavi","year":"2017","unstructured":"Shavi GV, Nayak UY, Reddy MS, Ginjupalli K, Deshpande PB, Averineni RK, et al. A novel long-acting biodegradable depot formulation of anastrozole for breast cancer therapy. Mater Sci Eng, C. 2017;75:535\u201344. https:\/\/doi.org\/10.1016\/j.msec.2017.02.063.","journal-title":"Mater Sci Eng, C"},{"key":"3173_CR45","first-page":"117","volume":"4","author":"T Higuchi","year":"1965","unstructured":"Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum. 1965;4:117\u2013212.","journal-title":"Adv Anal Chem Instrum"},{"key":"3173_CR46","doi-asserted-by":"crossref","unstructured":"Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. Translocation of Drug Particles in HPMC Matrix Gel Layer: Effect of Drug Solubility and Influence on Release Rate. Vol 70.; 2001. www.elsevier.com\/locate\/jconrel","DOI":"10.1016\/S0168-3659(00)00366-7"},{"issue":"9","key":"3173_CR47","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1021\/jp108540n","volume":"115","author":"J Gupta","year":"2011","unstructured":"Gupta J, Nunes C, Vyas S, Jonnalagadda S. Prediction of solubility parameters and miscibility of pharmaceutical compounds by molecular dynamics simulations. J Phys Chem B. 2011;115(9):2014\u201323. https:\/\/doi.org\/10.1021\/jp108540n.","journal-title":"J Phys Chem B"},{"issue":"19","key":"3173_CR48","doi-asserted-by":"publisher","first-page":"14699","DOI":"10.1021\/acs.energyfuels.3c02507","volume":"37","author":"Y Huang","year":"2023","unstructured":"Huang Y, Liang Y, Masuda Y, Cui W, Tsuji T, Matsuoka T, et al. Evaluation of asphaltene hildebrand and hansen solubility parameters using digital oil models with molecular dynamics simulation. Energy Fuels. 2023;37(19):14699\u2013713. https:\/\/doi.org\/10.1021\/acs.energyfuels.3c02507.","journal-title":"Energy Fuels"},{"issue":"11","key":"3173_CR49","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1039\/c6ra26146a","volume":"7","author":"S Xiong","year":"2017","unstructured":"Xiong S, Chen S, Jin S, Zhang Z, Zhang Y, Li L. Molecular dynamic simulations on TKX-50\/HMX cocrystal. RSC Adv. 2017;7(11):6795\u20139. https:\/\/doi.org\/10.1039\/c6ra26146a.","journal-title":"RSC Adv"},{"key":"3173_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/J.POWTEC.2011.12.046","volume":"219","author":"M Barzegar-Jalali","year":"2012","unstructured":"Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, Mohammadi G, Hamidi A, Andalib S, et al. Comparison of physicochemical characteristics and drug release of diclofenac sodium\u2013eudragit\u00ae RS100 nanoparticles and solid dispersions. Powder Technol. 2012;219:211\u20136. https:\/\/doi.org\/10.1016\/J.POWTEC.2011.12.046.","journal-title":"Powder Technol"},{"key":"3173_CR51","doi-asserted-by":"publisher","unstructured":"Ishtiaq M, Manzoor H, Khan IU, Asghar S, Irfan M, Albekairi NA, et al. Curcumin-loaded soluplus\u00ae based ternary solid dispersions with enhanced solubility, dissolution and antibacterial, antioxidant, anti-inflammatory activities. Heliyon 2024;10(14). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34636","DOI":"10.1016\/j.heliyon.2024.e34636"},{"key":"3173_CR52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.powtec.2012.12.038","volume":"237","author":"RN Shamma","year":"2013","unstructured":"Shamma RN, Basha M. Soluplus\u00ae: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technol. 2013;237:406\u201314. https:\/\/doi.org\/10.1016\/j.powtec.2012.12.038.","journal-title":"Powder Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03173-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T03:51:47Z","timestamp":1753933907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03173-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03173-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"180"}}